HemoShear Therapeutics

0 followers

HemoShear Therapeutics develops new treatments for patients with rare metabolic disorders.


Org chart

Brian Wamhoff
Interim CEO
Collapse
Jeffrey Qureshi
VP, Legal Affairs
Mike Simmers
VP, Operations
Paul Sartori
AVP, Organizational Development & Human Resources
Ryan Feaver
Executive Director, Head Of Exploratory Biology
Mark Hayes
Acting Chief Regulatory Officer
Teri Edwards
Executive Administrative Assistant

Board & advisors